Australia markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
311.29+32.90 (+11.82%)
At close: 04:00PM EDT
311.95 +0.66 (+0.21%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close278.39
Open313.39
Bid311.16 x 200
Ask311.48 x 100
Day's range308.72 - 322.60
52-week range211.71 - 329.72
Volume9,616,094
Avg. volume2,915,998
Market cap166.987B
Beta (5Y monthly)0.60
PE ratio (TTM)44.47
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield9.00 (2.89%)
Ex-dividend date16 May 2024
1y target estN/A
All
News
  • PR Newswire

    AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

    Amgen (NASDAQ:AMGN) today announced financial results for the first quarter 2024.

  • PR Newswire

    AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024

    Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference taking place May 12-22 in San Diego. Thirteen abstracts supporting two approved medicines and one investigational treatment will be presented.

  • PR Newswire

    AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS

    Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.